U.S. Markets open in 5 hrs 29 mins

Sernova Corp. (SVA.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2900-0.0100 (-3.33%)
At close: 3:46PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3000
Open0.2950
Bid0.2850 x N/A
Ask0.2950 x N/A
Day's Range0.2900 - 0.3000
52 Week Range0.1000 - 0.3500
Volume107,950
Avg. Volume415,168
Market Cap56.824M
Beta (5Y Monthly)1.41
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Does The Sernova Corp. (CVE:SVA) Share Price Tend To Follow The Market?
    Simply Wall St.

    Does The Sernova Corp. (CVE:SVA) Share Price Tend To Follow The Market?

    If you're interested in Sernova Corp. (CVE:SVA), then you might want to consider its beta (a measure of share price...

  • Is Sernova (CVE:SVA) In A Good Position To Deliver On Growth Plans?
    Simply Wall St.

    Is Sernova (CVE:SVA) In A Good Position To Deliver On Growth Plans?

    We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

  • Sernova Announces Biotech Veteran as New Chief Financial Officer
    CNW Group

    Sernova Announces Biotech Veteran as New Chief Financial Officer

    LONDON and ONTARIO , California , Oct. 24, 2019 /CNW/ -- Sernova Corp. (SVA.V) (SEOVF) (PSH.F), a clinical-stage regenerative medicine company, is pleased to announce that Mr. David Swetlow , CPA, CA, has joined Sernova as Chief Financial Officer. Adding a full-time CFO at this inflection point for the company with our recent announcement of initial positive early efficacy indicators for our Cell Pouch(TM) Phase I/II US clinical trial for type-1 diabetes and ongoing business development activities will accelerate execution of the company's financial, business and capital markets goals and strategies," said Dr. Philip Toleikis , President and CEO of Sernova. Sernova's outgoing CFO, Mr. Sean Hodgins , will assist with the transition as he continues to provide contract CFO services to his technology company clients.